Clinical Trial Update: Paclitaxel and Irinotecan in Advanced Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 1/2 study of paclitaxel and irinotecan in advanced gastric cancer; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Advanced Gastric Cancer | Phase 1, Phase 2 | Status: COMPLETED